| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775239 | Urology | 2018 | 9 Pages |
Abstract
The effectiveness of metallic stents in the management of malignant ureteric obstruction is unclear. This systematic review evaluates the use of 4 commercially available metallic stents (Resonance, Memokath 051, Uventa, and Allium URS). Twenty-one studies met eligibility criteria. Overall success rates ranged from 88% for the Allium stent to 65% for Memokath 051. Resonance demonstrated the lowest migration rate (1%). Uventa had the lowest obstruction rate (6%). Metallic ureteric stents offer a viable alternative in the management of malignant ureteric obstruction. Further high quality studies are required to assess cost effectiveness and refine specific indications based on etiology and level of the ureteric obstruction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Christopher C. Khoo, Hamid Abboudi, Rufus Cartwright, Tamer El-Husseiny, Ranan Dasgupta,